Sun Pharmaceutical Industries

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue4,7146,0694,6305,2035,151
Expenses4,2084,1614,0914,2964,329
EBITDA1,0672,4811,1121,4931,436
EBIT636.97-868.82547.821,100966.39
Profit Before Tax506.08-1,030389.88906.52751.47
Net Profit486.73-1,021380.64888.63721.31
Financial Ratios
Operating Profit Margin23.46%-7.88%21.97%29.74%27.86%
Net Profit Margin10.70%33.05%12.01%17.70%16.08%
Earning Per Share (Diluted)2.00-4.301.603.703.00
Dividends Per Share7.500.000.000.008.50
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ